Drugs / Calcium leucovate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04341857 Background | Jul 2019 → May 2022 | gastroesophageal adenocarcinoma | Henan Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium leucovate | “Calcium leucovate#200mg/m2d1#iv infusion#” NCT04341857 ↗ |
| Route | Intravenous | “Calcium leucovate#200mg/m2d1#iv infusion#” NCT04341857 ↗ |